Conference abstract · 22 May 2022
Conference abstractPublished 8 Aug 2022
Improving HDL functions by interaction with novel bioactive lipids
Mother Teresa Hospital, Albania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atherosclerosis is a chronic disease characterized by an accumulation of lipids and oxidized lipids within the intima of the arterial wall, which leading to cardiovascular diseases (CVD) such as heart attacks and strokes. High density lipoprotein (HDL) with its complex structure, plays an important role in preventing atherosclerosis due to its antiatherogenic properties. Improving HDL function and quality are expected to attenuate atherosclerosis and reduce CVD risk. Methods: we isolated a novel active compound from Nannochloropsis microalgae (LysoDGTS), which increased activities of the main antioxidant enzyme associate to HDL, (paraoxonase 1-PON1). Our aim is to examine the effect of lyso-DGTS on rePON1 and HDL activities in vitro, in vivo and ex vivo. Results: Lyso- DGTS increased activities of PON1 and increased HDL cholesterol efflux from macrophages in a dose-dependent manner and significantly increased the ability of HDL to induce nitric oxide (NO) production from endothelial cells. In an ex-vivo experiment, HDL obtained from5 patients, with plaque stenosis > 50% as determined by cardiac CT, was incubated with \ without lyso-DGTS and measured for its HDL efflux ability. In average, HDL efflux significantly increased in a dose dependent matter after incubation with lysoDGTS. In serum obtained from apoEKO mice treated with Lyso –DGTS for 28 days, LysoDGTS increased activities of PON1 and enhanced HDL cholesterol efflux. Conclusion: Novel bioactive lipids based on Lyso-DGTS derivatives interact selectively with HDL components and alter its structure and functions. Improving HDL functions using LysoDGTS and its derivatives might be a novel approach for reducing atherosclerosis development and decreasing CVD risk. Keywords: Atherosclerosis, HDL, lyso-DGTS, cholesterol efflux, nitric oxide, PON1.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Jan 2022
Dyslipidemia that Embraces Elevated Triglycerides, Low Levels of HDL-C, and Qualitative Lipid Abnormalities
Short communication · Aug 2021
Dyslipidemia that Encompasses Elevated Triglycerides, Low Levels of HDL-C, and Qualitative Lipid Abnormalities
Conference abstract · 2017
Concerns about the use of non-HDL cholesterol as a lipid predictor
Research article · 2016
The APJ Receptor A445C C Mutant Carrier Improves HDL Metabolism in Korean CVD Patients
More from this journal
The newest in Journal of Interventional and General Cardiology.
Commentary · 1 Dec 2025
Atrial Shunts: A New Hope for Heart Failure
Commentary · 1 Dec 2025
Biomechanics of Transcatheter Mitral Valve Leaflet Coaptation
Brief report · 1 Dec 2025
Percutaneous Myocardial Partitioning: Impact on Septal Mechanics
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Interventional and General Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Ali Khattib”

